Branded Generics Market

Branded Generics Market: Oncology Therapeutic Application Segment Expected to Grow Significantly in Developed Markets over the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016 –2026

  • 2020-01-17
  • REP-GB-1260
  • 39 Tables
  • 126 Figures
  • 222 pages
  • PDF PPT EXCEL
Branded Generics Market

An Incisive, In-depth Analysis on the Branded Generics Market

This study offers a comprehensive, 360 degree analysis on the Branded Generics market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Branded Generics market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Increasing prevalence of chronic and lifestyle diseases expected to create demand for branded generics over the assessment period

The global branded generics market size was valued at more than US$ 190 Bn in 2015 and is expected to witness a 7.3% CAGR over the forecast period (2016–2026). The market is projected to be valued at more than US$ 410 Bn by 2026. The global branded generics market is expected to represent incremental opportunity of nearly US$ 220 Bn between 2016 and 2026. Rising number of comorbidities like diabetes and cardiovascular diseases is creating ample opportunities for new and existing players in the global branded generics market.

Global Branded Generics Market Value (US$ Bn) By Therapeutic Application, 2016-2026

Cardiovascular diseases application segment expected to hold a large market revenue share over the projected period

The cardiovascular diseases segment was estimated to account for 11.8% market share of the global branded generics market by 2016 end and is expected to gain 102 BPS by 2026 over 2016. Cardiovascular diseases segment is expected to register high Y-o-Y growth throughout the forecast period. The segment was expected to reach a value of nearly US$ 25 Bn by 2016 end and is projected to remain the dominant segment during the forecast period. The dermatology diseases segment is expected to register moderate Y-o-Y growth as compared to other segments throughout the forecast period. Revenue contribution of this segment to the global branded generics market is expected to increase at a CAGR of 6.0% over the forecast period. In terms of value, the cardiovascular diseases segment is expected to register the highest CAGR of 8.2% during the assessment period. The neurology and dermatology diseases segments are expected to remain the least attractive segments in the global branded generics market in revenue terms with an attractive index of 0.5 each over the forecast period.

Diabetes segment market revenue share projected to grow at a significant CAGR owing to increasing prevalence of diabetes in Asia Pacific and MEA regions

The Diabetes segment is estimated to create absolute $ opportunity of US$ 1.6 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 7.7% from 2016 to 2026 to reach a value of nearly US$ 45 Bn by 2026. The Oncology segment is estimated to create absolute $ opportunity of US$ 1.1 Bn in 2017 over 2016. Revenue from this segment is projected to exhibit a CAGR of 6.9% from 2016 to 2026 to reach a value of more than US$ 30 Bn by 2026. The Neurology segment is estimated to create absolute $ opportunity of US$ 0.8 Bn in 2017 over 2016. Revenue from this segment is projected to register a CAGR of 6.1% from 2016 to 2026 to reach a value of about US$ 25.0 Bn by 2026. The Analgesics and Anti-inflammatory segment is estimated to create absolute $ opportunity of US$ 0.9 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 6.6% from 2016 to 2026 to reach a value of nearly US$ 30 Bn by 2026.

branded generics market_Image for preview analysis

Increasing out-of-pocket healthcare expenditure and patent expiries of blockbuster drugs fuelling the global branded generics market

As per Future Market Insights analysis, Branded Generics in the Emerging Markets such as Brazil, Russia, India and China are the most lucrative markets for branded generics. A big aspect that is fuelling the global branded generics market is the increasing out-of-pocket expenditure on healthcare in both emerging and developed economies. In addition, patent expiries of blockbuster drugs is also positively impacting the global branded generics market growth. Analysts working on this report have noticed a trend of mergers and acquisitions amongst the key market players to help consolidate their position in the global branded generics market. 

Frequently Asked Questions about Branded Generics Market

How the market is expected to grow during forecast period?

Increasing demand for affordable drugs across the world, especially in Asian countries driving the growth of branded generics market

Which product segment would be most attractive for investments in branded generics market?

Others segment which includes drug classes such as oral anti-diabetics, antibiotics, antivirals, and NSAIDs is expected to maintain its dominance during the forecast period.

Which therapeutic application segment would be most prominent in branded generics market over the forecast period?

Others segment which includes renal disorders, infections, respiratory diseases and several other diseases is expected to be the prominent segment in terms of revenue over the forecast period.

Which countries contribute maximum revenue share in branded generics market during the forecast period?

Countries such as the U.S., China, India, Russia and Brazil are expected to be the top five countries in terms of revenue market share

Which are top market players in the branded generics market?

Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., and Abbott Laboratories are some the largest market players, whereas regional generic manufacturers plays significant role in shaping the market in terms of revenue share.

Future Market Insights recently published an insightful market research report providing an in-depth overview of the branded generics market highlighting the parameters influencing the market during the forecast period 2016-2026. With a complete assessment of the branded generics market, this research report showcases the growth opportunities of the market by providing extensive information related to the various factors of the branded generics market. Future Market Insights have covered major market aspects and provided a wider picture of the branded generics market, by tracing key aspects such as trends, opportunities, market drivers and restraints pertaining to the market.

Extensive Impact Analysis of the Branded Generics Market

The report offers a complete analysis of the branded generics market with a focus on various aspects related to the market. The extensive impact analysis of the market provides a comprehensive understanding of the global market influencers and the exclusive inclusion of impact analysis of the growth driver and restraints helps clients and key players in decision-making and succession planning pertaining to the future prospects for the branded generics market significantly.

With a closer peek into the market the report examines various aspects that illustrate the current market scenario including an overview of the demand for branded generics and a region-wise analysis to understand the global scenario of the branded generics market. With an illustrative future outlook of the market, the report significantly covers various future prospects for the branded generics market that could fuel the growth of the market in the forecast period.

Market Dynamics Shaping the Future of the Market

The report utilizes a broader approach to mention the global branded generics market landscape, ensuring complete coverage of the market dynamics contributing to the branded generics market as a whole. The value-added insights related to the macroeconomic factors, supply and demand side drivers, expansion and growth opportunities, market trends as well as restraints impacting the market adversely are included in the report.

The global market trends and opportunities for the branded generics market are the key takeaways of the publication with a detailed understanding of the how the new advancements and developments witnessed by the market are shaping the future of the market. The analysis of the key market players and manufacturers round the globe and their shift towards a strategic approach are highlighting the market scenario in the future.

Competitive Analysis for Understanding Competitive Landscape of the Market

The report provides a thorough information of the competitive landscape with the help of competitive analysis model, to help established players and new entrants in strategic decision making. With an extensive market study regarding the competitive landscape, the report examines the market capabilities with an in-depth regional segmentation and market value differentiated by region.

The tables and figures give a detailed outlook of the market scenario for the market players and their current as well as forecasted positions in the market throughout the forecast period. A unique dashboard of the competitive landscape highlights the challenges, opportunities and strategic actions carried out by global branded generics market leaders, helping the new entrants understand the market better. With the inclusion of SWOT analysis for each key player explicitly, along with their major developments and a strategic overview featured in the branded generics market, the report serves as a great industry analysis tool.

Segmentation and Differentiation

The report gives a brief introduction to the branded generics market and the segmentation of the market by formulation type, therapeutic application, drug class, distribution channel, and region. The research study ensures a complete understanding for the reader in terms of market segmentation. With a thorough analysis of the branded generics market on the basis of drug class and therapeutic application differentiation, the report provides a revenue forecast for the forecasted period. Similarly, it presents forecast in terms of value for formulation type, distribution channel, and regional segmentation.

Research Methodology

With an extensive primary and secondary research conducted to understand the global branded generics market scenario, analysts at Future Market Insights have carried out research with a systematic approach. The forecast presented in the report highlights actual data pertaining to the current scenario along with the data provided for the forecasted period to understand the dynamically changing branded generics market. With in-depth and detailed data analysis the report provides key information for the reader for gaining a competitive edge in the branded generics market.

Branded Generics Market Reports - Table of Contents

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology